When I was 19 years old, I visited New York for ten days on the way to London. I was flying from New Zealand, that small ...

Overture heads back to the past to build on its twisted rendition of Pinocchio, telling a compelling story that throws you into combat with creative enemies in varied environments ...

The XboxEra crew are in LA for Summer Game Fest, and I got to sit down with the lovely Johnny Galvatron from developer ...

Other activities during the summer will include a special 4-H Storytime at 10 a.m. June 14, when local 4-H members will read ...

If you’re just joining us after the intermission, Lies of P is one of the better soulslikes to take the stage in a very crowded genre. Aside from its unique weapon-crafting system, it didn’t introduce ...

Elon Musk may have “left Washington” last week, but the Department of Government Efficiency won’t miss a step. That’s because Musk was never running DOGE in the first place. I’m not suggesting that ...

Raising Hell for free on VPesports! This way you can join the adventure with our guide for easy access via Steam. Enjoy the ...

Congressional and DOJ investigations examine allegations that White House staff secretly ran the Biden presidency, ...

Your average cult band might make a handful of great, overlooked albums, split up in frustration, and eventually reunite to ...

Any showers will clear this evening, turning dry. Tonight will then remain dry with lengthy clear spells, and just a few light patches of cloud around. Monday Tomorrow morning will see areas of ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.